Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design Read more
Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for oligonucleotides Read more
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease Read more
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Read more
Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management Read more
BioVersys Announces Expansion of Strategic Collaboration with GSK and Extension of its Series C Round by CHF 12.3 Million Read more
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines Read more
Aspaveli (pegcetacoplan) approved in Europe for use among treatment naïve adult patients with PNH Read more